The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...
In today's enterprise landscape, software development often resembles a game of telephone. Business users articulate needs, and—after those needs go through layers of marketing, product and ...
Jon Bircher outlines seven recommendations to get the most from all company functions and ensure optimal brand planning. As more and more organisations have moved to cross-functional and ...
In this interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, discusses stumbling blocks to process development; strategies for developing, scaling up, and ...
Optimising the R&D-to-commercialisation handover process is crucial for the survival of young biotech companies. While many sectors were dealt a punishing blow during the pandemic, Covid-19 ushered in ...
Product development is the lifeblood of the medical device industry. Patients look to device makers to improve quality of life and to ensure that safe, effective products are developed and ...
A distinctive feature of our industry is the enormous variety of capabilities that must be combined to develop and execute a strategy. More than almost any other industry, bringing a new medicine or ...
It’s said that doctors make the worst patients. In contrast, it turns out that the company that builds a work management platform is incredibly good at work management — or at least monday.com is ...
In an era influenced by powerful algorithms, the intersection of SEO and PR is crucial but often overlooked by enterprise leadership. This partnership has its challenges. PR may not always acknowledge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback